Colorcon acquires Paulaur Corporation’s pharmaceutical sugar spheres business

The addition of the Paulaur products complements Colorcon’s Suglets Sugar Spheres product line and enhances Colorcon’s position as a leading global supplier of sugar spheres for the development of multiparticulate dosages.

The addition of the Paulaur products complements Colorcon’s Suglets Sugar Spheres product line and enhances Colorcon’s position as a leading global supplier of sugar spheres for the development of multiparticulate dosages. The agreement is specific to Paulaur sugar spheres sold into the pharmaceutical and nutritional segments globally.

Colorcon provides speciality excipients for pharmaceutical and nutraceutical applications worldwide, and has identified strong synergies between the multiparticulate and film coating businesses. Colorcon is well‐positioned to serve pharmaceutical and nutraceutical spheres customers thanks to its range of immediate, delayed and extended release coatings and previous investment in the multiparticulate business.

Pankaj Rege, General Manager for Colorcon Manufactured Products explains: “There is strong demand in the industry for a supplier who offers high quality product, application and formulation support with a multi‐facility business continuity plan. This acquisition complements Colorcon’s existing investment in its people, capabilities, and organization, which have consistently delivered superior products and services to Colorcon’s pharmaceutical and dietary supplement customers.”

Mitchell Stefaniak, Vice President and Chief Financial Officer of Paulaur Corporation, commented that “Paulaur had made the decision to leave the pharmaceutical and nutraceutical spheres arena to concentrate on our fast‐growing food and confectionary business. At the same time, we wanted to insure that our pharmaceutical and nutraceutical spheres customers could be assured of a continued availability of quality product. The sale to Colorcon provides our customers with just such a supplier.”

Martti Hedman, Colorcon’s CEO states: “Paulaur’s pharmaceutical sugar spheres business is an exciting strategic acquisition for Colorcon. This announcement comes at the end of another strong year for us, with growth across all business areas. Colorcon views this agreement as an opportunity to expand Colorcon's sugar spheres business and leverage our global distribution, technical service, and sales infrastructure."

Colorcon provides a full range of products and services for solid oral dosage formulations and continues to see growth in multiparticulate dosages forms, especially for geriatric and pediatric populations. Due to this agreement, Colorcon and Paulaur customers stand to benefit with direct access to products, technical service and support from Colorcon.